Entos Pharmaceuticals Inc.

Canada


Commandez votre montre hebdomadaire Entos Pharmaceuticals Inc.
Quantité totale PI 39
Rang # Quantité totale PI 36 934
Note d'activité PI 2,4/5.0    30
Rang # Activité PI 25 543
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

10 9
5 5
7 0
3
 
Dernier brevet 2025 - Sars cov-2 vaccine, associated p...
Premier brevet 2003 - Membrane fusion proteins derived...
Dernière marque 2023 - PLV
Première marque 2020 - ENTOS

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Sars cov-2 vaccines, associated polynucleotides, and methods of use. The present disclosure rela...
Invention Sars cov-2 vaccines, associated polynucleotides, and methods of use. The present disclosure relat...
Invention Proteolipid vesicles formulated with fusion associated small transmembrane proteins. Disclosed i...
2023 P/S Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic pro...
P/S Diagnostic reagents for clinical laboratory use; diagnostic preparations for clinical laboratory ...
Invention Dna therapeutic encoding an antibody or antigen binding fragment. The present disclosure relates...
Invention Dna therapeutic encoding an antibody or antigen binding fragment. The present disclosure relates ...
2022 Invention Sars cov-2 vaccine, associated polynucleotides, and methods of use. The present disclosure relat...
Invention Sars cov-2 vaccine, associated polynucleotides, and methods of use. The present disclosure relate...
Invention Compositions and methods for liver-specific expression of follistatin. Provided herein are expres...
Invention Recombinant polypeptides for membrane fusion and uses thereof. Disclosed is a recombinant polype...
P/S Custom manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic pr...
P/S Pharmaceutical and medicinal preparations and substances, namely, human vaccines; chronic disease...
P/S Reagents for scientific purposes for use in nucleic acid isolation and purification; cell culture...
2021 Invention Methods for diagnosing and treating metastatic cancer. Disclosed are methods of diagnosing and tr...
P/S chemical and biological agents for scientific and research use. pharmaceuticals; pharmaceutical p...
P/S Chemical and biological agents for scientific and research use Pharmaceuticals; pharmaceutical pr...
Invention Proteolipid vesicles formulated with fusion associated small transmembrane proteins. Disclosed is...
P/S research and development in the field of computational biology, bioinformatics, and genomics; pro...
2020 P/S Downloadable software for optimizing the development and discovering of new and existing molecule...
2019 Invention Recombinant polypepties for membrane fusion and uses thereof. Disclosed is a recombinant polypept...
2018 Invention Recombinant oncolytic viruses for treatment of metastatic cancers. Disclosed are recombinant onco...
2012 Invention Membrane fusion proteins derived from reovirus. In accordance with the present invention, a fami...
2011 Invention Recombinant polypeptides for membrane fusion and uses thereof. Disclosed is a recombinant polypep...
2010 Invention Membrane fusion proteins derived from reovirus. In accordance with the present invention, a famil...